title: Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss.
abstract: BACKGROUND
  15% of reproducing couples suffer from pregnancy loss(PL) and recurs in 2-3%. One of the most frequently hypothesized causes of unexplained PL refers to a defective maternal haemostatic response leading to uteroplacental thrombosis. Hereditary thrombophilia and antiphospholipid antibodies have been extensively described as risk factors for PL in women with unknown aetiology. Recently, a new marker has emerged: the cell-derived procoagulant circulating microparticles(MPs) which have been reported to have a major role in many thrombosis complicated diseases. This study aims to analyze the significance of procoagulant MPs in women suffering from unexplained recurrent pregnancy loss(RPL), and characterize their cellular origin.
  
  
  RESULTS
  115 women with RPL were analyzed for common thrombophilia markers and different cell derived MPs-total annexinV, platelet(CD41a), endothelial(CD146,CD62e), leukocyte(CD45), erythrocyte(CD235a) and tissue factor(CD142)(TF) expressing MPs and were compared with 20 healthy non-pregnant women. Methodology for MP analysis was standardized by participating in the "Vascular Biology Scientific and Standardization Committee workshop".
  
  
  RESULTS
  Total annexinV, TF and endothelial MPs were found significantly increased(p<0.05, 95% confidence interval) in women with RPL. The procoagulant activity of MPs measured by STA-PPL clotting time assay was found in correspondence with annexinV MP levels, wherein the clot time was shortened in samples with increased MP levels. Differences in platelet, leukocyte and erythrocyte derived MPs were not significant. Thirty seven of 115 women were found to carry any of the acquired or hereditary thrombophilia markers. No significant differences were seen in the MP profile of women with and without thrombophilia marker.
  
  
  CONCLUSIONS
  The presence of elevated endothelial, TF and phosphatidylserine expressing MPs at a distance (at least 3 months) from the PL suggests a continued chronic endothelial damage/activation which may get exaggerated at the onset of pregnancy. The data suggests that MPs may contribute to uteroplacental thrombosis and are associated with the pathogenesis of RPL.
authors.affiliation: Department of Haemostasis and Thrombosis, National Institute of Immunohaematology (ICMR), KEM Hospital, Parel, Mumbai, India.
authors.forename: Rucha
authors.initials: R
authors.lastname: Patil
authors.forename: Kanjaksha
authors.initials: K
authors.lastname: Ghosh
authors.forename: Purnima
authors.initials: P
authors.lastname: Satoskar
authors.forename: Shrimati
authors.initials: S
authors.lastname: Shetty
mesh_terms: D000026:Abortion, Habitual / Q000097:blood / Q000276:immunology / Q000378:metabolism*; D000328:Adult; D017152:Antibodies, Antiphospholipid; D015415:Biomarkers / Q000097:blood; D001780:Blood Coagulation Tests; D016022:Case-Control Studies; D055252:Cell-Derived Microparticles / Q000378:metabolism*; D005260:Female; D006801:Humans; D011247:Pregnancy; D019851:Thrombophilia / Q000097:blood / Q000378:metabolism; D055815:Young Adult
chemical_list: D017152:Antibodies, Antiphospholipid; D015415:Biomarkers